Search Results

Site Search

Bobbi Pritt, M.D., Discusses Minnesota Bugs to Watch out for This Summer - Insights

In a recent article in the Star Tribune, Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, weighs in on bugs present in Minnesota to watch out for this...

Guidance on subtyping of influenza A test results - Insights

Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients

Week in Review: March 31 - Insights

Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.

Melanoma - Insights

Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.

Malabsorption disorders - Insights

Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...

Liquid biopsy - Insights

Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.

Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights

When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.

Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

T-cell Lymphoma [Test in Focus] - Insights

Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.

Instruções para pagamento internacional - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Ceramide testing helps reduce risk of heart attack: Stephanie Blendermann - Insights

Her father was a heavy smoker who eventually needed bypass surgery for his clogged arteries, and three of her sisters died prematurely from heart attacks. So, as Stephanie Blendermann approached the age of 65, she had good reason to think...

A downward spiral undone: Jon Bratsch - Insights

Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...

Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights

An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

Rare patient case helps inform and validate GABA-A-R antibody encephalitis testing: JoAnne Michael - Insights

JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

Cardiovascular Biomarkers of Atherosclerotic Risk - Insights

In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.

MML - 24 Hour Stool Collection - Spanish - MC5424-21SP

MML - 24 Hour Stool Collection - Spanish - PATIENT EDUCATION Instrucciones para la recoleccio de heces Stool Collection Instructions Spanish Por favor lea toda la informacio

hepatitisbtesting-algorithmforscreeningdiagnosismanagement.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2024 Result Profile Table Test ID Test Name HBs antigen HBs antibody (Ab) HBc total Ab HBc IgM Ab HBe antigen HBe Ab HAV total Ab HAV IgM Ab HCV...

Autoimmune testing education - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...

Pathways Case Studies: May 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Cytopathology, Gastroenterology...

Michael Camilleri, M.D., and Leslie Donato, Ph.D., Discuss Testing for Bile Acid Malabsorption in Clinical Practice - Insights

In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of...

Week in Review: May 6 - Insights

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights

David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASSFIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...

Dr. Dong Chen and Dr. Sounak Gupta join Becker's Healthcare Podcast to discuss molecular testing in cancer care - Insights

Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...

Leveraging Lessons from the Past - Insights

Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.

MAG Antibody Testing [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...

New tests launched in August - Insights

In August 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

https://www.mayocliniclabs.com/-/media/mediax/customer-service/mayoaccess/ma-workstation-setup-guide.pdf?sc_lang=en&hash=80F7F54389FE5FFAE754B5711FC4EF75

MayoACCESS® Workstation Setup Guide Page 2 4/28/25 MayoACCESS Workstation Setup Guide TABLE OF CONTENTS Introduction...

MCL Microbiology Test Request MC0767

MCL Microbiology Test Request Complete print Reset Form Microbiology Test Request Client Information required Client Patient Information required Patient ID Medical Record

Autoimmune evolution - Insights

Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...

Myeloid neoplasms - Insights

Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.

MayoComplete - Insights

Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.

Colorectal Cancer NGS Testing - Mayo Clinic Laboratories

Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.

Lung Cancer NGS Panel - Mayo Clinic Laboratories

Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.

When the Body Attacks the Brain: Immune System Often to Blame for Encephalitis, Study Finds - Insights

Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.

Ticks and the Art of Finding Beauty in Dreadful, Wonderful Parasites - Insights

Bobbi Pritt, M.D., spends her work hours identifying and diagnosing infectious diseases. In her free time, she celebrates their beauty by creating bug-related artwork and blogging about parasites.

Resources - Insights

The Resources page features a compilation of valuable education and content not specific to a program type.

Phlebotomy - Insights

The Phlebotomy Resource Page is a compilation of on demand content, presentations, and other phlebotomy-related education.

Phlebotomy - Insights

A repository of Phlebotomy related education.

Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights

Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.

Addiction rehab monitoring assay - Insights

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories' unique approach to urine drug testing for addiction rehabilitation. Designed to guide and monitor therapy, the comprehensive profile tests for the most...

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D. - Insights

Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC - Insights

Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for...

NELL-1 [Test in Focus] - Insights

Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...

Reclaiming her joy: Joy Carol - Insights

A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness...

New tests launched in September - Insights

In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Test Utilization Practices for Venous Thromboembolism: A Model of Cost Savings and Efficiency at Mayo Clinic - Insights

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.

Phlebotomy Top Gun: Safe Handling of Laboratory Specimens During the COVID-19 Pandemic - Insights

In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., addresses the safe handling of laboratory specimens submitted during the COVID-19 pandemic through his yearly Phlebotomy Top Gun presentation based on the previous year’s Phlebotomy...